Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
H
196300
vs
K
KOSPI 200
Over the past 12 months, HLB Pep Co Ltd has underperformed KOSPI 200, delivering a return of +2% compared to KOSPI 200's +125% growth.
Stocks Performance
196300 vs KOSPI 200
Performance Gap
196300 vs KOSPI 200
Performance By Year
196300 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
HLB Pep Co Ltd
Glance View
HLB Pep Co., Ltd. engages in the development and production of therapeutic peptides. The company is headquartered in Gwangju-Metropolitan, Gwangju and currently employs 88 full-time employees. The company went IPO on 2016-12-07. The firm engages in the manufacturing and sales of pharmaceuticals, raw pharmaceuticals, and quasi-drugs. The firm also engages in life research and development related to peptide-based therapeutics.